Inventor · disambiguated record
Anders Nykjær
Also filed as: NYKJAER ANDERS
2 granted patents·15 pending applications·50 citations·filing 2009–2023
65Inventor score
Top patents by PatentIndex Score
17 records- 0185US8460657B2Modulation of the TrpV: Vps10p receptor system for the treatment of painNYKJAER ANDERS·Filed 2009·Granted Jun 11, 2013·39 cites·5 claims
- 0280US8703125B2Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disordersPEDERSEN SIMON GLERUP·Filed 2009·Granted Apr 22, 2014·11 cites·8 claims
- 0355US2025161321A1Amino acid based carbamates and/or ureas for the treatment of sortilin dependent diseasesVESPER BIO APS·Filed 2023·Application pending·0 cites
- 0455US2025268854A12-amino-5,5-dimethylhexanoic acid derivatives as sortilin modulators for use in the treatment of disease of the central nervous systemc/o Vesper Bio ApS·Filed 2022·Application pending·0 cites
- 0553US2024294569A1Modulators of sortilin activityINSUSENSE ApS·Filed 2022·Application pending·0 cites
- 0651US2024217922A1Modulators of sortilin activityINSUSENSE ApS·Filed 2022·Application pending·0 cites
- 0750US2015299304A1Modulation of the VPS10P-Domain Receptors for the Treatment of Cardiovascular DiseaseLUNDBECK & CO AS H·Filed 2015·Application pending·0 cites
- 0850US2023374143A1A sortilin antagonist for use in the prevention or treatment of hearing lossINSUSENSE ApS·Filed 2021·Application pending·0 cites
- 0950US2024132514A1Pyridine derivatives as modulators of sortilin activityINSUSENSE ApS·Filed 2022·Application pending·0 cites
- 1049US2017318057A1Modulation of the VPS10P-Domain Receptors for the Treatment of Cardiovascular DiseaseH LUNDBECK AS·Filed 2017·Application pending·0 cites
- 1146US2023044608A1Compounds for treatment of eye diseasesUNIV AARHUS·Filed 2020·Application pending·0 cites
- 1242US2022033470A1Compositions Comprising Sortilin-1INSUSENSE ApS·Filed 2019·Application pending·0 cites
- 1341US2016060346A1Modulation of Activity of ProneurotrophinsLUNDBECK & CO AS H·Filed 2015·Application pending·0 cites
- 1440US2015166629A1SorCS1 FOR USE IN THE TREATMENT OF OBESITY AND OVERWEIGHTUNIV AARHUS·Filed 2013·Application pending·0 cites
- 1537US2013115212A1Modulation of the Interaction between SorLA and GDNF-Family Ligand ReceptorsNYKJAER ANDERS·Filed 2011·Application pending·0 cites
- 1633US2015239973A1Modulation of the Interaction Between SorLA and GDNF-Family Ligand ReceptorsLUNDBECK & CO AS H·Filed 2015·Application pending·0 cites
- 1731US2016349276A1Use of Sortilin as Biomarker for Affective/Mood DisordersH LUNDBECK AS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anders Nykjær files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →